Karyopharm to merge with Ayrmid in Chapter 11 restructuring
Karyopharm and Ayrmid Ltd. agreed to a merger under Chapter 11 bankruptcy, and Karyopharm secured $55 million in financing to continue operations and support its patients.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed